fragilis). Compared to community-acquired infections, healthcare-associated infections typically involved a broader spectrum of microorganisms, encompassing ESBL-producing Enterobacteriaceae, Enterococcus, Pseudomonas, and Candida click here species in addition to the Enterobacteriaceae, Streptococcus species, and anaerobes typically observed in community-acquired IAIs. The threat of antimicrobial resistance has become a major challenge in the management of intra-abdominal infections. The main resistance threat is posed by ESBL-producing Enterobacteriaceae, which are frequently found in community-acquired infections. According to the
study’s preliminary findings, ESBL producers were the most prevalent and commonly identified drug-resistant microorganism. Two isolates of Klebsiella pneumoniae appeared to be resistant to Carbapenems. These particular infections were acquired in the intensive care unit. Wortmannin The rate of Pseudomonas aeruginosa among aerobic isolates was 4.6%. There was no statistically significant difference in the Pseudomonas appearance rate between community-acquired and healthcare-associated IAIs. Enterococci (E. faecalis and E. faecium) were identified in 14.5% of all aerobic isolates. Although Enterococci were also present in community-acquired infections, they were far more prevalent in healthcare-associated infections. Data currently available in
mainstream Ergoloid literature regarding the infectious trends of Candida species are rather contradictory . In the first half of the CIAO Study, 45 Candida isolates (5.7%) were observed among a total of 825 isolates. Candida prevalence was significantly higher in the healthcare-associated IAI group than it was in the community-acquired IAI group. Of the 912 patients enrolled in the study, there
were 58 deaths (6.4%). According to univariate statistical analysis of the data, critical clinical condition of the patient upon hospital admission (defined by severe sepsis and septic shock) as well as healthcare-associated infections, non-appendicular origin, generalized peritonitis, and serious comorbidities such as malignancy and severe cardiovascular disease were all significant risk factors for patient mortality. WBCs greater than 12,000 or less than 4,000 and core body temperatures greater than 38°C or less than 36°C by the third post-operative day were statistically significant indicators of patient mortality. Conclusion Complicated intra-abdominal infections remain an important cause of morbidity with poor clinical prognoses. The purpose of the CIAO Study is to describe the epidemiological, clinical, microbiological, and treatment profiles of both community-acquired and healthcare-acquired complicated intra-abdominal infections (IAIs) based on the data collected over a six-month period (January 2012 to June 2012) from 66 medical institutions.